REGN

REGN Total Current Assets

$18.45BQuarterly · USD

Period ending:

REGN FY Current AssetsUSD
REGN FY Current Assets1990-12-31: $22.40M1991-12-31: $106.60M1992-12-31: $84.70M1993-12-31: $91.80M1994-12-31: $52.00M1995-12-31: $49.20M1996-12-31: $85.00M1997-12-31: $99.60M1998-12-31: $92.90M1999-12-31: $73.00M2000-12-31: $134.14M2001-12-31: $394.19M2002-12-31: $276.95M2003-12-31: $320.21M2004-12-31: $343.96M2005-12-31: $341.39M2006-12-31: $469.98M2007-12-31: $797.83M2008-12-31: $521.44M2009-12-31: $425.51M2010-12-31: $720.05M2011-12-31: $913.59M2012-12-31: $1.62B2013-12-31: $2.25B2014-12-31: $2.51B2015-12-31: $3.38B2016-12-31: $3.91B2017-12-31: $5.60B2018-12-31: $7.96B2019-12-31: $7.69B2020-12-31: $9.78B2021-12-31: $14.01B2022-12-31: $15.88B2023-12-31: $19.48B2024-12-31: $18.66B2025-12-31: $18.02B$19.48B$0.00
1990-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

REGN total current assets history

Assets expected to be converted to cash within one year. The available annual fiscal periods series contains 36 observations from Dec 31, 1990 to Dec 31, 2025.

Regeneron Pharmaceuticals Total Current Assets — Annual fiscal periods (USD)
Period endingTotal Current Assets (USD)
18,021,900,000
18,660,900,000
19,479,200,000
15,884,100,000
14,014,900,000
9,779,100,000
7,689,100,000
7,959,300,000
5,596,552,000
3,913,920,000
3,383,756,000
2,506,894,000
2,252,208,000
1,620,787,000
913,585,000
720,051,000
425,508,000
521,442,000
797,829,000
469,984,000
341,392,000
343,955,000
320,207,000
276,948,000
394,186,000
134,142,000
73,000,000
92,900,000
99,600,000
85,000,000
49,200,000
52,000,000
91,800,000
84,700,000
106,600,000
22,400,000

Compare total current assets

All REGN financial metrics · REGN stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.